官方APP下载:英语全能特训(微信小程序版,支持苹果手机、安卓手机)
创办于2003年
UNSV记不住?那就记中文谐音“忧安思危”吧!
  Slow and Steady Wins the Race!
UNSV英语学习频道 - Slow and steady wins the race!
公众微信服务号
英语全能特训(微信公众服务号)
UNSV英语学习频道淘宝网店
客服短信:18913948480
客服邮箱:web@unsv.com
初级VIP会员
全站英语学习资料下载。
¥98元/12个月

Study: AIDS Drug Not Linked to Depression, Suicide

阅读次数:


VIP会员专享下载:(非VIP会员无权下载!如果想下载,但还不是VIP会员,请点此订购
下载方式:使用鼠标右键(注意是鼠标右键!)点击下面的MP3音频/MP4视频链接,然后选择“另存为…”。
MP3节目录音 MP3节目录音 
文章原文
同步字幕

A new study of a popular medicine could ease concerns about its link to depression.

The drug, efavirenz, is used to fight the human immunodeficiency virus, HIV. The virus weakens the body’s natural defenses.

Some researchers once feared that using efavirenz caused patients to become depressed or consider the possibility of suicide. Researchers working in Uganda reported recently that the drug did not cause those negative side effects.

Efavirenz is a low-cost, once-a-day pill used around the world to treat and prevent HIV and the disease AIDS. It is 'the treatment of choice' in most of the world, especially in countries that depend on international aid to treat HIV. That information comes from Mark Siedner of the Africa Health Research Institute.

Some studies in the United States and Europe found the drug increased patients' risk of depression or suicide. But other studies did not reach the same finding.

The mixed results led many doctors in the United States to suggest more costly but possibly safer drugs.

Siedner wanted to take another look at the risk of depression, this time in Africa. From 2005 until 2015, he and a team of Ugandan and U.S. doctors followed 694 patients. All of the patients took either efavirenz or another antiretroviral medication. The doctors asked the subjects whether they experienced depression or ideas of suicide.

No difference

A report on the study was published in the Annals of Internal Medicine.

Siedner says he and his team found there was no difference between the two treatments.

He told VOA, 'In other words, efavirenz was not associated with a risk of depression. If anything, there seems to be a signal that…potentially it was associated with a decreased risk. But it wasn't a strong enough [signal] for us to say that.'

The researchers also noted that 17 of the patients died during the study. But there was not a single death from suicide.

Siedner has two possible explanations for why their findings differed from those in Western countries. He said one possible cause “is that every single ethnic group in the world, of course, is different, and different in many different ways. Different socially, different environmentally, and in this case, they may be different genetically.' His team is looking at whether the genes that control the metabolism of the drug have an effect to play in this story.

A second explanation could be the effectiveness of the drug. Because efavirenz is so powerful, it could be keeping people healthier than they expected. As a result, patients might be less likely to report depression or suicidal thoughts.

Anthony Fauci, a leader in AIDS research for over 30 years, praised the new study as important. He heads the U.S. National Institute of Allergy and Infectious Diseases.

He said the study pushes back against 'the initial observation of suicidal ideation, and suicide and depression' as caused by efavirenz.

He told VOA, 'I think now what you're seeing is that with these conflicting reports, it's likely someone will come in [with] the proposal to do a randomized study and take a look. So the story isn't ended with this paper.'

As more research on the safety of efavirenz is done, new and less costly drugs that might replace it are likely in the future. One of them, dolutegravir, might also create a health risk, however. A study in Botswana found dolutegravir was linked to neural tube defect in embryos. That means it might not be safe for pregnant women.

As always, more research is needed to confirm whether this is a common problem or only affected the population in Botswana.

I’m Susan Shand.

This story was reported by Sadie Witkowski of VOA News. Susan Shand adapted it. George Grow was the editor.

Write to us in the Comments Section or on our Facebook page.

Words in This Story

negativeadj. harmful or bad; unwanted

associate – v. to think of one person or thing when you think of another person or thing

metabolism – n. the chemical processes by which a plant or an animal uses food and water to grow and heal and to make energy

randomizedadj. of or related to something lacking aim, direction or rule

neural tube – n. a structure from which the brain and spinal cord form

网友的学习评论(0条):
版权所有©2003-2019 南京通享科技有限公司,保留所有权利。未经书面许可,严禁转载本站内容,违者追究法律责任。 互联网经营ICP证:苏B2-20120186
网站备案:苏ICP备05000269号-1中国工业和信息化部网站备案查询
广播台